Evonik (Pharma)

Parsippany, NJ (US) · United States

Contract Development & Manufacturingmid

Specialization: Functional Coatings & Drug Delivery

Key Differentiator

Part of Evonik Industries (€15.3B); dominates functional coating market with EUDRAGIT range; expanded lipid excipients for mRNA/LNP platforms (Jan 2025); integrated excipient + CDMO

Core Services

EUDRAGIT (enteric/sustained release coatings), RESOMER (biodegradable polymers for drug delivery), lipid excipients for LNP/mRNA, CDMO services for parenteral drug delivery

Capabilities

EUDRAGIT (enteric/sustained release coatings)RESOMER (biodegradable polymers for drug delivery)lipid excipients for LNP/mRNACDMO services for parenteral drug delivery

Market Intelligence

Parenteral excipients growing at 8.23% CAGR; plant-based excipients = 18.23% share (2024)

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.